Page last updated: 2024-08-17

methylene blue and End Stage Liver Disease

methylene blue has been researched along with End Stage Liver Disease in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Armour, S; Ritter, MJ; Smith, BB; Warner, MA1

Other Studies

1 other study(ies) available for methylene blue and End Stage Liver Disease

ArticleYear
Cardiopulmonary Bypass Ultrafiltrate Discoloration After Hydroxocobalamin Administration.
    The Annals of thoracic surgery, 2019, Volume: 107, Issue:1

    Topics: Adult; Blood Loss, Surgical; Cardiopulmonary Bypass; Color; Diagnosis, Differential; End Stage Liver Disease; Enzyme Inhibitors; Heart Valve Diseases; Heart Valve Prosthesis Implantation; Humans; Hydroxocobalamin; Male; Methylene Blue; Nitric Oxide Synthase; Pharmaceutical Solutions; Postoperative Complications; Ultrafiltration; Vasoconstrictor Agents; Vasoplegia

2019